One study [44] observed fewer activated CD8+ T cells in invasive breast cancer than in-ductal carcinoma in situ (DCIS), proposing that immune evasion occurs during the transition from DCIS to invasive cancer. Here, CD8A is linked to ductal breast carcinoma in situ.